|
|
The discovery of the gene that causes IP will not have a practical impact on IP patients or their families for some time, until the biology of the product of the gene is understood.
Research into therapies and better ways to treat specific symptoms must proceed while geneticists and biochemists strive to uncover the molecular mysteries of NEMO
But there is reason for hope. It may be possible to manipulate other biochemical pathways to compensate for the loss of function of NEMO.
For certain, the discovery of NEMO now allows for a more assured molecular diagnosis in prenatal cases.
|
|
|
|
|
